Vistin Pharma ASA (DE:VP4) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Saga Pure ASA increased its stake in Vistin Pharma ASA, acquiring 50,000 shares at a price of NOK 28.2 each, now holding a total of 700,000 shares. This purchase, conducted on the Oslo Stock Exchange, represents a 1.58% ownership in Vistin Pharma and is linked to board member Øystein Stray Spetalen.
For further insights into DE:VP4 stock, check out TipRanks’ Stock Analysis page.